Cardioloxía
Servizo
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublicacións en colaboración con investigadores/as de David Geffen School of Medicine at UCLA (5)
2020
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
2019
-
Effects of serelaxin in patients with acute heart failure
New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726
2016
-
Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II
European Heart Journal, Vol. 37, Núm. 33, pp. 2591-2601
2015
-
Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients
BMC Cardiovascular Disorders, Vol. 15, Núm. 1
2011
-
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Journal of Heart and Lung Transplantation, Vol. 30, Núm. 3, pp. 252-269